Announcements Trials

Browse Landscape

Phase

Phase 2 8 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 3 INDUSTRY 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

sintilimab 1 diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine 1 Vincristine 1 Sevoflurane 1 Rituximab 1 Propofol 1 Pleurodesis 1 Mitoxantrone 1 Methotrexate 1 Introns 1 Interferon alpha-2 1 Idarubicin 1 Gastrointestinal Microbiome 1 Drug Therapy 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Danazol 1 Cytarabine 1 Clorazepate Dipotassium 1 Carboplatin 1 Anesthesia, Epidural 1 23-valent pneumococcal capsular polysaccharide vaccine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NETWORK × Dasatinib × Clear all

NCT05944783 2025-02-12

BE-Dasatinib

Centro de Atencion e Investigacion Medica

Phase 4 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡